) describe different approaches to visualizing threedimensional bone and tooth structures on both macro scopic and nanometre scales. The methods derive from computed tomography, a well-established imaging technique that can yield 3D pictures of bones, but which quantifies just one scalar parameter, such as mineral density, in each voxel (3D pixel) of the image. Using the new techniques, each voxel contains information on both the orientation and the size of mineral particles in the bone or tooth specimen.
The strength of bone is determined by its structure on all scales, particularly by local variation in the size, amount and orientation of bone mineral particles 3 . Formed from calcium phosphate, these mineral platelets are just a few nanometres thick and are embedded in a matrix of collagen molecules (Fig. 1,  inset) . Because bone tissue is constantly remodelled and adapted, the orientation of mineralized collagen fibrils varies in a complex fashion throughout the tissue 4 . Although transmission electron microscopy provides sufficient resolution to visualize the mineral particles, it does not allow them to be mapped over millimetre distances in complete bone sections. For this reason, a technique called small-angle X-ray scattering (SAXS) has been used in a 'scanning' mode since the 1990s to study bone taken from patient biopsies and animals 5, 6 . In this method, a bone specimen is moved in two dimensions (defined by the x and y axes in Fig. 1 ) across a narrow X-ray beam, and at each position of this scan a SAXS pattern is collected. This allows the simultaneous visualization of two different scales: the structure, particularly the orientation, of the mineralized collagen fibrils in every pixel of the scan; and the variation of fibril orientation across a macroscopic specimen.
When a 2D X-ray detector is used, as in the early implementations of scanning SAXS, it effectively provides 4D information: a macro scopic 2D map of the bone tissue and 2D information about the structure of the mineralized collagen fibrils in every pixel of the map 7 . It is straightforward to extend this to five dimensions by rotating the bone section around an axis to collect 3D information on the mineralized collagen fibrils in each voxel, while the mapping stays 2D 8 . It would be desirable to extend this to six dimensions by enabling 3D macroscopic mapping of the specimen. But the reconstruction of such 6D data is a formidable numerical challenge and can be solved only through the use of certain approximations and substantial computing power. In conventional computed tomography, volumes are reconstructed from 2D images taken in the x-y plane for many rotation angles φ around a given axis (Fig. 1) . For SAXS tomography, 2D SAXS data must be collected at each position of the x-y plane and at many rotation angles, not just around one axis but around many axes. This results in a huge number of measurements and requires massive computational effort.
To make such efforts tractable, Liebi et al. (page 349) take advantage of certain symmetries in the mineralized collagen fibrils of bone. More specifically, they assume that the arrangement of mineral particles is rotationally symmetricalit looks the same after a certain amount of rotation -around the direction in which collagen molecules align in each fibril. This symmetry imposes constraints on the SAXS patterns that aid the reconstruction of 3D images using a procedure sometimes called tensor tomography.
Schaff and colleagues' approach (page 353) assumes that the SAXS signal varies slowly with rotation angle. This means that fewer rotation angles are needed during data collection, because data values between rotation angles can be interpolated. The authors used their technique to study dentine in the interior of a tooth. Both techniques 1,2 produce 3D pictures of macroscopic specimens, in which each voxel contains an arrow that represents the direction of the predominant orientation of the mineralized collagen fibrils in the voxel.
A previous attempt 9 to develop 3D scanning-SAXS tomography was devised for materials with structures that have rotational symmetry around one axis, such as composite materials based on parallel fibres. This approach is similar to that of Liebi and colleagues, but it assumes that all the fibres point in the same direction throughout the specimen, which is not true for bone. Another recently reported approach 10 applies normal scanning SAXS to a series of consecutive thin bone sections cut 1,2 report methods for SAXS tomography that enable multi-scale analysis of bone and tooth structures. A sample (here, a bone specimen) is scanned by a narrow X-ray beam in the x and y directions for various rotation angles φ around an axis through the sample. The scans provide 2D maps that are combined to produce a 3D reconstruction of the bone structure. Unlike conventional methods for visualizing bones, SAXS tomography provides both a 3D macroscopic map of the sample and 3D information on the nanoscale mineral particles embedded in the collagen molecules of bone (such as their predominant direction of alignment; purple arrow in inset). 
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W O L F-D I E T R I C H H A R DT
T he pathogenic bacterium Staphylococcus aureus causes thousands of deaths each year. Therapy is sometimes unsuccessful, partly because antibiotic-resistance genes are spreading worldwide. However, even strains of S. aureus that lack resistance genes are often difficult to kill with available anti biotics; it has been suggested that the bacteria 'hide' inside host cells. This hypothesis inspired Lehar et al. 1 , who, on page 323 of this issue, present a construct in which an antibiotic is linked to an antibody that binds to the pathogen's surface. Alone, this 'prodrug' is inactive, but when prodrug-coated bacteria enter host cells, enzymatic activity releases the anti biotic. In mouse models of S. aureus infection, this strategy was strikingly more potent than standard antibiotic treatment.
Antibiotics are a pillar of modern medicine, but they are not effective in all cases. There are at least three explanations for this. First, important pathogenic bacteria, including many S. aureus strains, have acquired resistance against standard antibiotics 2 . Second, the pathogen may hide in host sites that cannot be reached by antibiotic molecules, or where the environmental conditions, such as high acidity, render the antibiotics inactive. And third, in certain circumstances, bacteria can switch to a 'persistent' lifestyle that makes them insensitive to antibiotics 3 . The switch to persistence is still not completely understood but can occur in some pathogens when they enter host cells.
In S. aureus, a range of virulence factors manipulate host-cell processes, prohibit efficient immune responses and fuel infections in wounds, the bloodstream and other sites. In the absence of antibiotic-resistance genes, several different classes of antibiotic are used to treat S. aureus infections; rifampicin anti biotics are sometimes employed to target intracellular reservoirs of the bacterium. However, these classic antibiotics are often unable to cure the infection.
Lehar and colleagues speculated that this failure is due to either insufficient accessibility of the antibiotic or insufficient activity against intracellular S. aureus. In an attempt to overcome these problems, the researchers first generated a rifampicin derivative (a 'rifalogue') with altered physicochemical properties that gives superior activity against S. aureus cells that have switched to a persistent lifestyle. Next, they identified an antibody that tightly binds to sugar structures found on the surface of all S. aureus strains tested. Then they covalently joined these two components by using a chemical bridge that can be broken by protease enzymes that are present at the intra cellular sites where S. aureus is thought to hide out (Fig. 1) . Strikingly, in a mouse infection model, this antibody-antibiotic conjugate (AAC) was much more effective at reducing pathogen loads than two conventional antibiotics currently used to treat recalcitrant S. aureus infections.
This approach is reminiscent of antibodytargeted prodrug strategies that are currently used in cancer therapy 4 , and these proof-ofprinciple data suggest that targeted antibiotic delivery is a promising strategy for fighting obstinate intracellular pathogens. It remains to be seen whether AACs are as efficient at 
